Zymeworks Announces Participation in Upcoming Investor Conferences

Author's Avatar
Feb 28, 2023

Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: